Global Community Should Continue To Invest In TB Eradication Efforts

Project Syndicate: The Return of a Forgotten Killer
Bjørn Lomborg, visiting professor at the Copenhagen Business School and director of the Copenhagen Consensus Center

“…TB not only gets scant attention, but also a fraction of health funding. … Such complacency is dangerous. Despite a compelling economic and moral case for investing more in controlling the disease, it has quietly resumed its position as the world’s leading infectious killer, claiming more lives than either HIV or malaria. … In high-prevalence countries, there can be no argument that governments and donors need to focus more on TB. … Unlike diseases like Ebola or Zika, TB seldom makes headlines. It should. Given all that we know about how to prevent and treat TB, and a powerful economic case for investing in eradication efforts, there is no excuse for the heavy toll that it continues to take” (2/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.